The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: a meta-analysis of randomized trials

Li, Bob T., Barnes, Tristan A., Chan, David L., Naidoo, Jarushka, Lee, Adrian, Khasraw, Mustafa, Marx, Gavin M., Kris, Mark G., Clarke, Stephen J., Drilon, Alexander, Rudin, Charles M. and Pavlakis, Nick 2016, The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: a meta-analysis of randomized trials, Lung Cancer, vol. 102, pp. 21-27, doi: 10.1016/j.lungcan.2016.10.004.

Attached Files
Name Description MIMEType Size Downloads

Title The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: a meta-analysis of randomized trials
Author(s) Li, Bob T.
Barnes, Tristan A.
Chan, David L.
Naidoo, Jarushka
Lee, Adrian
Khasraw, MustafaORCID iD for Khasraw, Mustafa orcid.org/0000-0003-3249-9849
Marx, Gavin M.
Kris, Mark G.
Clarke, Stephen J.
Drilon, Alexander
Rudin, Charles M.
Pavlakis, Nick
Journal name Lung Cancer
Volume number 102
Start page 21
End page 27
Total pages 7
Publisher Elsevier Ireland
Place of publication Shannon, Ireland
Publication date 2016-12
ISSN 0169-5002
1872-8332
Keyword(s) Angiogenesis
lung cancer
meta-analysis
tyrosine kinase inhibitors
Angiogenesis Inhibitors
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
Combined Modality Therapy
Disease-Free Survival
Human body
Lung Neoplasms
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Randomized Controlled Trials as Topic
Receptors, Vascular Endothelial Growth Factor
Vascular Endothelial Growth Factor A
Science & Technology
Life Sciences & Biomedicine
Oncology
Respiratory System
MOTESANIB PLUS CARBOPLATIN/PACLITAXEL
PHASE-II
DOUBLE-BLIND
1ST-LINE TREATMENT
TUMOR ANGIOGENESIS
PLACEBO
VANDETANIB
DOCETAXEL
PACLITAXEL
BEVACIZUMAB
Language eng
DOI 10.1016/j.lungcan.2016.10.004
Field of Research 1112 Oncology And Carcinogenesis
1103 Clinical Sciences
HERDC Research category C1.1 Refereed article in a scholarly journal
ERA Research output type C Journal article
Copyright notice ©2016, Elsevier Ireland Ltd.
Persistent URL http://hdl.handle.net/10536/DRO/DU:30109285

Document type: Journal Article
Collections: Faculty of Health
School of Medicine
Molecular and Medical Research
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 3 times in TR Web of Science
Scopus Citation Count Cited 2 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 34 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Tue, 12 Jun 2018, 09:34:27 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.